DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

Celgene (NASDAQ: CELG)

123.04 3.81 (3.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $123.04 3.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $120.97
Previous Close $119.23
Daily Range $119.25 - $123.33
52-Week Range $83.16 - $140.72
Market Cap $97.3B
P/E Ratio 45.16
Dividend (Yield) $0.00 (0.0%)
Volume 5,775,668
Average Daily Volume 5,001,260
Current FY EPS $4.22

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

10 Reasons Why It's So Easy to Fall in Love With Celgene

A handy list of 10 reasons why Celgene may be at the head of the class in a very crowded biotech sector.

Kyle Bass's Latest IPR Missile Ventures Into Biologics And Threatens Amgen's $5B Enbrel Drug

Comments On The Market Correction; Focus On Biotechs: Large Caps

Short Sellers Become More Focused in Major Biotechs

Jim Cramer Advises His Viewers On Wells Fargo, Receptos And Celgene

AstraZeneca: A High-Yield Play In The Burgeoning Oncology Field

Jason Napodano On Biotech: Potential M&A Activity, Partnerships And Women's Health

M&A Daily: Free Dan Loeb!

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

Why Acorda Therapeutics, Inc. Stock Surged Higher Today

Acorda Therapeutics' stock soared today after the USPTO declined to review two key patents for the company's multiple sclerosis drug Ampyra.

See More CELG News...

CELG's Top Competitors

CELG $123.04 (3.20%)
Current stock: CELG
AMGN $155.72 (1.13%)
Current stock: AMGN
BIIB $304.49 (2.09%)
Current stock: BIIB
GILD $107.99 (0.96%)
Current stock: GILD